Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ethereum Price Prediction: ETH Near $2,324 as Remittix’s $0.28 Entry Meets Its $0.46 Final Presale Stage
-
Miranda Lambert To Kick Off Salvation Army's Red Kettle Campaign With Dallas Cowboys Thanksgiving Game Halftime Performance
-
Solana Price Today: SOL Near $100.54 as Alpenglow Targets 150ms Finality and Remittix Plans a 300M RTX Burn
-
Vantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams
-
Next 100x Crypto? Remittix, Zcash and Hyperliquid in Focus as BNB Chain Expands Tokenized Stock Trading
-
Crypto Price Prediction: Bitcoin’s Market Share Takes Focus as Remittix’s $33M Raise Meets a 300M RTX Burn Plan
-
XRP Price Prediction: Arf Brings Its $10B Annual Settlement Business to XRPL as Remittix Plans 41 More Fiat Currencies
-
Dogecoin News Today: Dogecoin Labs Unites Teams Behind 500,000-User Wallet as Remittix Plans a 20% Supply Cut
-
Best Crypto Presale to Buy in 2026? Can Remittix’s 300M RTX Burn Plan Outshine Solana and Zcash?
-
Pathway Law Firm Retained to Represent Heir of Levi Brown Following Fatal Shooting at Bakersfield High School Football Game
-
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
-
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
-
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
-
Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 202
-
Crypto News: Oil Ends the Week Near $117 as Bitcoin Holds Around $80K and Remittix Plans a 300M RTX Burn
-
TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
-
In HelloNation, Insulation Expert Mike Mancuso Explains Why Air Sealing Should Come Before Adding Insulation
-
Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
-
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
-
Polygon Price Prediction: German Savings Banks Add POL as Remittix Plans 41 More Fiat Currencies
-
HBAR Price Prediction: Hedera Joins Five Groups Pressing SEC as Remittix Earn Readies Morpho, Fluid and Maple Finance Pools
-
Best Crypto Presale 2026: JPMorgan Adds Two Funds to Solana as Remittix Recruits 100 Earn Testers
-
The Exhibition Hall of Achievements of China's Language Resources Protection Project Officially Opens
-
Best Altcoin to Buy: $134B Left Altcoins, Yet Pepeto Buyers Keep Coming as NEAR and QNT Wait
-
Crypto News Today: $431M Shaken Out as ETH and XRP Reset, While Cofounder Builds Pepeto
-
Crypto Update: Ethereum’s Four-Minute Settlement Proposal Meets Remittix Earn’s 18-22% APY Test Offer
-
Chainlink Price Prediction: LINK Near $11.30 After LG CNS Deal as Remittix Earn Readies Aave, Morpho and Fluid Pools
-
Litecoin Price Prediction: Can LTC Reclaim $63 as Remittix Plans a 64.3% Presale Price Increase?
-
SOL, ETH and Remittix: Best Crypto Presale to Buy as Earn Prepares Aave, Morpho and Fluid Pools?
-
Crypto News: Bitcoin and XRP Face Oil’s $117 Close as Remittix Invites Earn Testers With Weekly Payouts
-
Bitcoin News: Tesla-SpaceX Merger Talks Put Their BTC Holdings in Focus as Remittix Plans a 300M RTX Burn
-
Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
-
Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
-
Nekteck Makes Everyday Relaxation and Recovery More Accessible With Practical Wellness Products
-
Crypto News: Remittix Announces 300 Million RTX Burn at Launch as JPMorgan Brings Two Tokenized Funds to Solana, Building the Case for a $300 SOL Price Prediction
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
-
LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026
-
Ethereum Price Prediction: ETH Near $2,324 as Four-Minute Proposal Meets Remittix’s 100-Tester Earn Offer
-
Crypto News Today: Swiss Retail Bitcoin ETF Approval Meets Remittix’s $0.28 Entry and November Launch Countdown
-
Dr. Anna Nolin Highlights Human-Centered Leadership as Schools Navigate the Next Phase of Artificial Intelligence
-
ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
-
Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration
-
Bitcoin Price News: ETFs Added $1B Earlier This Week as Remittix Recruits 100 Earn Testers
-
XRP Price Today: XRP Near $1.29 as Wallets Hit 8.24M and Remittix Prepares a 20% Supply Cut
-
New Crypto Watch: Monero Gains Around 2% as Remittix’s $33M Raise Meets a Planned 300M RTX Burn
-
Binance New Listing Watch: Alpha Removes Seven Tokens as Remittix Prepares Its November 24 Debut
-
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati
-
Come Back to Firefox: Mozilla launches its most ambitious campaign yet to bring people back to the independent alternative to big tech browsers
-
TRON Price Prediction: $23M Revenue Report Beats ETH and SOL Combined as Remittix Plans 41 More Fiat Currencies
-
AirTripMaker Launches Comprehensive Flight Tickets to India Routes Guide from the USA and Canada to Major Indian Destinations
